These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 9665476

  • 1. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 2. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
    Kaune KM, Neumann C, Hallermann C, Haller F, Schön MP, Middel P.
    Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
    [Abstract] [Full Text] [Related]

  • 4. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A, Miturski R, Skomra D, Jakowicki JA.
    Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
    [Abstract] [Full Text] [Related]

  • 5. Expression of the RB protein, allelic imbalance of the RB gene and amplification of the CDK4 gene in metaplasias, dysplasias and carcinomas in Barrett's oesophagus.
    Sarbia M, Tekin U, Zeriouh M, Donner A, Gabbert HE.
    Anticancer Res; 2001 Jan; 21(1A):387-92. PubMed ID: 11299766
    [Abstract] [Full Text] [Related]

  • 6. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
    Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H.
    Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
    [Abstract] [Full Text] [Related]

  • 7. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T, Henke C, Korabiowska M, Schlott T, Zimmerman B, Kunze E.
    Anticancer Res; 2004 Oct; 24(2B):1011-23. PubMed ID: 15161057
    [Abstract] [Full Text] [Related]

  • 8. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 9. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J, Akusjärvi G, Goike HM, Roos G, Collins VP, Pettersson RF.
    Cell Growth Differ; 2000 Jul 10; 11(7):373-84. PubMed ID: 10939591
    [Abstract] [Full Text] [Related]

  • 11. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 12. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 13. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J, Kratzke RA, Niehans GA, Lincoln CE.
    Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382
    [Abstract] [Full Text] [Related]

  • 15. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 15; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 16. [Expression and regulation of p16 in osteosarcoma].
    Shi X, Ma Z, Wang D, Liang Y, Li H, Wang J.
    Zhonghua Wai Ke Za Zhi; 1999 Dec 15; 37(12):733-6. PubMed ID: 11829939
    [Abstract] [Full Text] [Related]

  • 17. [The expression of p16, CDK4 and pRb in hepatocellular carcinomas].
    Luo D, Liu Q, Su J.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 15; 7(2):94-5. PubMed ID: 10488417
    [Abstract] [Full Text] [Related]

  • 18. Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma.
    Mohseny AB, Tieken C, van der Velden PA, Szuhai K, de Andrea C, Hogendoorn PC, Cleton-Jansen AM.
    Genes Chromosomes Cancer; 2010 Dec 15; 49(12):1095-103. PubMed ID: 20737480
    [Abstract] [Full Text] [Related]

  • 19. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines.
    He J, Olson JJ, James CD.
    Cancer Res; 1995 Nov 01; 55(21):4833-6. PubMed ID: 7585516
    [Abstract] [Full Text] [Related]

  • 20. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y, Yoshimoto T, Sekiya T.
    Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.